We have evaluated in situ hybridization histochemistry as a means of estimating simultaneously the level of prohormone mRNA and the dimensions of rat pancreatic islets. Localization of the 27-mer 32P-labeled oligonucleotide probes for rat proinsulin I, glucagon, and prosomatostatin I corresponded with localization of antibodies to the three hormones. In normal rats subjected to chronic hyperglycemic clamping, the density of the proinsulin mRNA signal increased 54%, islet size and number increased =100%, while proglucagon mRNA signal was reduced 81%. Resection of 50% of the pancreas increased proinsulin mRNA 36% and proglucagon mRNA 500%; islet area doubled and islet number increased 50%. In 150-day-old diabetic ob/ob mice, there was an 18-fold expansion in islet area, a 4-fold increase in islet number, but no increase in insulin gene expression. In insulin-dependent streptozotocin-treated diabetic rats, islet area and number were profoundly reduced; insulin deprivation failed to raise proinsulin mRNA in surviving beta cells above control levels. Proglucagon mRNA was high despite the hyperglycemia but was reduced by insulin within 1 hr, suggesting that insulin regulates glucagon gene expression or is required for its regulation by glucose. In situ hybridization of rat islets provides a valid semiquantitative index of insulin and glucagon biosynthesis and of islet dimensions and reveals that normal but not diabetic islets meet increased insulin demand by increasing both number and biosynthetic activity of beta cells.
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Normal islets of Langerhans secrete sufficient insulin to maintain the plasma glucose in the normal range during metabolic stress. This compensatory response could involve either an increase of insulin biosynthesis and secretion or an expansion of beta cell mass or both. Since currently employed techniques do not permit quantitative assessment of these components of the compensatory response in the same pancreas, we have evaluated in situ hybridization histochemistry as a means of estimating simultaneously the molecular mRNA and the cellular responses to increased need for insulin production. (2) .
METHODS
In Situ Hybridization. The sections of pancreas were hybridized in situ with 32P-labeled 27-mer oligonucleotide probes synthesized from sequences of rat cDNA for proinsulin I (3), proglucagon (4) , and prosomatostatin I (5) . A tritiated poly(U) probe (Amersham) was also used. Probes (5'-3') were: proinsulin I, GAG CAG GGC CAG CAG GGG CAG GAA GCG; proglucagon I, GTC ACT GGT GAA TGT GCC CTG TGA ATG; prosomatostatin I, GCA GCC AGC 1TT GCG TTC CCG GGG TGC. They were labeled with polynucleotide kinase (New England Biolabs) (6) . Specific activities ranged from 2000 to 3000 Ci/mmol (1 Ci = 37 GBq). Two sections of each pancreas were hybridized with the proinsulin oligonucleotide, and two sections were hybridized with the proglucagon probe as described by Han et al. (7) .
Prohormone mRNA signal density (tLm2 of signal above threshold per ,um2 of cells containing that signal) was quantitated by digitizing dark-field images (10 times) of radioautographs under light microscopy by using a videometric 150 image analyzer (American Innovision, San Diego, CA). Islet area was determined by tracing with the screen cursor the boundaries of every islet cell group containing proinsulin mRNA signal. Control pancreata included in each hybridization run were compared by the Student t test for two groups. Indirect immunofluorescence staining for insulin, glucagon, and somatostatin was performed as described (8) .
oligonucleotide probes, their distribution in rat islets was compared with that of antibodies to the three hormones localized by immunofluorescence staining. Fig. 2 A and B) (P < 0.01). Endocrine area was more than twice that of the controls (P < 0.01), and the number of islets was almost double (Table 1) (P < 0.01).
Effects of Compensation for Partial Pancreatectomy on Proinsulin and Proglucagon mRNA and Islet Dimensions. To assess these parameters in compensation for another form of increased insulin need, normal rats were subjected to 50% pancreatectomy. Four weeks postoperatively they were aglycosuric, and glucose levels were only 18 mg/dl above controls-evidence of compensation. Proinsulin mRNA density in the pancreatic remnant was 36% above the control value (Table 1) (P < 0.01). Proglucagon mRNA density was 5 times the controls in this normally glucagon-poor region of pancreas (9), perhaps to compensate for the loss of the glucagon-rich splenic half. Islet area was twice that of the controls (P < 0.01), and islet number increased by half of the control value (P < 0.01).
Proinsulin mice were examined. In 60-day-old mice (mean glucose level, 317 ± 107 mg/dl; body weight, 44.3 ± 4.2 g), endocrine area was more than 6 times the control value (P < 0.01), and the number of islets was increased 2.7 fold (P < 0.01), but proinsulin mRNA density was only 21% above normoglycemic controls (Table 2) (P < 0.05). In 150-day-old ob/ob mice (mean glucose, 440 ± 108; body weight, 52.8 ± 6 g), the endocrine area was 18 times the control value (P < 0.01), and the number of islets was 4 times that of age-matched controls (Table 2 and Each value is the mean ± SEM of six pancreatic sections hybridized for insulin and for glucagon. Every islet in a section was counted. Only the distal half of the pancreas (tail) was counted. Numbers in parentheses indicate the percent change from the controls. *P < 0.05. tp < 0.01.
cin-treated rats. There was a profound reduction in endocrine area and in the number and size of islets in all treatment groups (Table 3 and Fig. 2C ), but prohormone mRNA density varied with the insulin treatment regime. To maintain euglycemia, some rats were treated with twice daily injections of isophane insulin until pancreatic resection (mean blood glucose level, 100 ± 23 mg/dl; glucagon, 295 ± 51 pg/ml). In this group proinsulin mRNA was undetectable, while proglucagon mRNA was slightly above levels in controls (not significant). In other rats insulin was discontinued 2-3 days before pancreatic resection (mean blood glucose, 426 ± 7 mg/dl; glucagon, 685 ± 51 pg/ml); in these rats the proinsulin mRNA signal was detectable, but its density was only 86% of normoglycemic control values, and proglucagon mRNA density was 80% above control values despite the severe hyperglycemia. Some insulin-deprived rats received 5 units of regular porcine insulin intraperitoneally 1 hr before pancreatic resection (blood glucose, 110 ± 50 mg/dl; glucagon, 248 ± 16 pg/ml); in these rats proinsulin mRNA was 32% of normal values, and proglucagon was 36% above control values.
DISCUSSION
We have evaluated in situ hybridization histochemistry as a means of simultaneously quantitating islet area and number and the density of proinsulin and proglucagon mRNA signals in the same pancreas. Localization of labeled oligonucleotides for proinsulin I, proglucagon, and prosomatostatin I corresponded with that of antibodies to insulin and glucagon, and observed changes in endocrine area and islet number during hyperglycemic clamping agreed with reports using other techniques (10) (11) (12) . Similarly, the marked expansion of the endocrine pancreas in ob/ob mice (13) and its depletion in streptozotocin-treated diabetic rats (8) confirm earlier observations made with conventional techniques. Thus, the morphometric capabilities of the technique appear comparable to other methods.
The measurements of prohormone mRNA by in situ hybridization also corresponded with direct and indirect estimates of hormone biosynthesis obtained with other techniques. For example, in this study the pancreatic remnant 4 weeks after 50% pancreatectomy in rats exhibited a 2.8-fold increase in proinsulin mRNA (islet area x proinsulin mRNA density), compared with a 2-fold increase in proinsulin mRNA observed with dot-blot hybridization 3 weeks after 50% pancreatectomy (14) . Although measurements of proinsulin mRNA after hyperglycemic clamping have not been reported previously, the in vivo increase in proinsulin mRNA observed here is consistent with the in vitro increase in insulin gene expression in isolated islets exposed to high glucose concentration (15, 16) . The inappropriately high level of proglucagon mRNA in insulin-deprived streptozotocintreated diabetic rats and its decline after insulin repletion is consistent with the hyperglucagonemia present in all forms of insulin-dependent diabetes (17, 18) and its suppression by insulin (19) . This correspondence between changes in islet hormone secretion reported in similar models using other techniques (17, 18) and the results described here suggests that in situ proinsulin and proglucagon mRNA signal density provide an index of biosynthetic activity in beta and alpha cells.
Therefore, in situ hybridization was used quantitatively to reveal the relative roles of enhanced insulin biosynthesis and expanded beta cell mass in the normal compensatory response to increased demand for insulin. Two novel observations were made. First, in neither of the diabetic models studied did hyperglycemia enhance insulin gene expression to the levels of normal rats subjected to hyperglycemic clamping. In the 150-day-old ob/ob mice, a 17-fold increase in "total" proinsulin mRNA per sections of pancreas (proinsulin mRNA density x the area of islets) was entirely the result of an expansion of endocrine tissue unabetted by a "per cell" increase in insulin biosynthesis despite the severe hyperglycemia. Similarly in the surviving beta cells of insulindeprived streptozotocin-treated diabetic rats, proinsulin (1989) mRNA density failed to rise above normoglycemic controls. Although the latter may reflect residual damage induced by streptozotocin 4 weeks earlier, the functionally insufficient glucose-stimulated enhancement of proinsulin mRNA in two unrelated forms of diabetes calls for further investigation of regulation of insulin gene expression in other forms of the disease. Second, insulin rapidly reduced the elevated proglucagon mRNA in insulin-deprived streptozotocin-treated diabetic rats, suggesting that normal regulation of glucagon gene expression by glucose is either mediated by insulin or requires insulin.
